The male god of magic capital

Chapter 168 Chapter 169 Frustrated the three major groups, gaining 100%
This Wang Yizhen is really a little housework expert, careful, serious, responsible, and quite caring. Luo Cheng is very satisfied with recruiting such a part-time worker.

But he won't have dinner at home tonight, he has an appointment tonight.

Immediately, Luo Cheng sent a message to Wang Yizhen, asking her to make her own food tonight.

Luo Cheng took a shower and drove to the Shangri-La Hotel. Tonight, he invited Zhou Yuanping, Zhang Hanlin, and Ling Guangchang to have dinner.

Before the three of them started Ogilvy Medicine, they each invested 2000 million.

As for Luo Cheng, the Luo Family Foundation invested 3 million yuan and bought 1200 million shares at an average price of 25 yuan per share.

Last Friday, Ogilvy Medical’s stock price closed at 40 yuan per share, with a floating profit of 15 yuan per share, a total floating profit of 1.8 million, and a net account value of 4.8 million.

Zhou Yuanping: "The male god, the stock price of Ogilvy Medical has soared to 40 yuan a share, and we plan to withdraw."

Zhang Hanlin: "I originally planned to hold it for a long time, but there was a huge dispute on Ogilvy Medical's board of directors, which may affect the company's stock price in the future. If you take a heavy position, be careful."

Luo Cheng asked: "I have been resting for the past two days, what's the situation with Ogilvy Medical?"

Ling Guangchang said: "Ogilvy Medical is the supplier of Fuxing Medicine, and Fuxing Medicine has won the rival Shenzhou Baekje Biotech in several technical fields before. Shenzhou Baekje Biological Company is ruthless, so it plans to acquire Ogilvy Medical , the key production links of Fuxing Medicine will be out of stock."

Luo Cheng was taken aback, he planned to hold the shares of Ogilvy and Mather for a long time, and if it was less than 50 yuan per share, it would not withdraw.

Behind this Shenzhou Baekje Biological Company is Tianhai Group, Nuoan Group, Jardine Group, Wu Tianhai and others should have made arrangements early to attack Ogilvy Medical, thus attacking the rival Fuxing Pharmaceutical.

"What is the purchase price?"

Ling Guangchang said: "The market price is 40 yuan per share. At present, the board of directors of Ogilvy Medical is still arguing, and Fuxing Medicine is firmly opposed. The forces of the two sides are competing. Fuxing Medicine is at a disadvantage. A shareholders' meeting will be held tomorrow. "

This is a struggle between Fuxing Medicine and Shenzhou Baekje Biological Company. Luo Cheng intends to get involved. Before Tianhai Securities, Jardine Securities, and Nuoan Securities engaged in his Chengtian Holding Company, which caused the stock price of Chengtian Holdings to plummet. The Tiangong fund has been redeemed in large numbers, and this time he has to work hard.

At the general meeting of shareholders, Shenzhou Baekje Biological Company must be prevented from acquiring Ogilvy Medical. After all, the Roche Family Foundation still holds 2500 million shares in Fuxing Pharmaceutical, a Hong Kong stock company.

Although Fuxing Medicine can find a supplier to replace Ogilvy Medical, if Shenzhou Baekje Biological Company acquires Ogilvy Medical, then this will be a pain for Fuxing Pharmaceutical's stock price.

Luo Cheng immediately said: "Everyone, don't sell the shares of Ogilvy Medical, I plan to prevent Shenzhou Baekje from acquiring Ogilvy Medical."

The four together hold more than 3% of Ogilvy Medical's shares and can vote at the shareholders' meeting, but they are only minority shareholders after all. Luo Cheng has to win over other shareholders to oppose Shenzhou Baekje's acquisition of Ogilvy Medical.

At present, Chen Haohua, the chairman of Ogilvy Medical, holds 15% of the shares. He is opposed to the merger and acquisition. Fuxing Medicine holds 5% of the shares, which adds up to 20%. However, there are other major shareholders who hope that Ogilvy Medical Acquired by Shenzhou Baekje Biological Company at a price of 40 yuan per share.

Immediately, Luo Cheng started calling to ask the clients of Chengtian Holdings to find a relationship, and he managed to win over many neutral shareholders that night, but the number of dissenting votes needed was not enough.

At this time, the bigwigs in the customer group spoke.

"Mr. Luo, I know a lady who holds a lot of shares in Ogilvy Medical and is an initial investor in Ogilvy Medical. Please talk to her. I will call you and I have notified her. .”

The major shareholder is Wan Xiangling, who holds a 9% stake in Ogilvy Medical.

This Wan Xiangling was found by Haotian Asset Management Company Zhang Haotian. Zhang Haotian is a major client of Chengtian Public Fund, and has invested 80 billion in it. Chengtian Public Fund has a huge income. Naturally, Zhang Haotian is willing to help, and Wan Xiangling and Haotian Asset Management Company has a deep cooperation. Zhang Haotian asked Wan Lingxiang to support Luo Cheng, and she would naturally help.

Wan Lingxiang said on the phone: "Mr. Luo, since Mr. Zhang asked me to help you, I will support you and vote against the acquisition of Ogilvy by Shenzhou Baekje Biotech."

As an initial investor of Ogilvy Medical, her goal is to make money. To be honest, she has no objection to Shenzhou Baekje's acquisition of Ogilvy Medical at a price of 40 yuan per share.

But Zhang Haotian approached her, and after weighing things up, she decided to oppose the acquisition.

Luo Cheng thanked: "Miss Wan, thank you."

After chatting, Luo Cheng called Zhang Haotian and thanked him.

Although the market value of Luo Cheng's Chengtian Holdings is not high, but the customers are powerful, and this social network is a burden. Luo Cheng brings benefits to them, and they will naturally help.

Zhang Haotian smiled and said: "Haha, it's a little effort, you're welcome."

After chatting for a while, Zhang Haotian said again: "Mr. Luo, the income of your Chengtian Public Fund is too stable. I plan to keep investing and will not redeem it!"

"Thank you, Mr. Zhang, for your trust." Luo Cheng smiled. Although the Chengtian Public Fund was redeemed a lot before, it did not lose money, and its income has been stable.

Luo Cheng: "Good!"

"When will you come to Xiyong to play, haha, I will treat you well." Zhang Haotian asked.

"I've been busy recently, let's wait until I'm free." Luo Cheng said.

"Buy a Gulfstream private jet. It will arrive in a few hours." Zhang Haotian laughed.

"Haha, let's talk about it when the time comes, I'm about to buy a private jet too, Mr. Zhang, we can fly the plane together in the future!" Luo Cheng laughed.

After chatting and ending the phone call, Luo Cheng was a little speechless, why does Zhang Haotian like to show off his Gulfstream private jet so much, in Luo Cheng's eyes, Gulfstream is a high-end product, okay?

In the future, I will come to a private jet worth 5 million or 10 billion U.S. dollars, take a look!
It's a pity that the scale of Chengtian Holding Company is not large enough, and Luo Cheng is not in a hurry.

In the future, let’s talk about the market value of Chengtian Holdings over 150 billion yuan. Today’s market value is only [-] billion, which is too small. Even the market value of Tianhai Securities is much higher than Chengtian Holdings.

On the night of Monday, February 2th, Ogilvy Medical held a general meeting of shareholders.

The shareholders meeting of Ogilvy Medical has attracted many attentions.

"This time Ogilvy Medical will definitely be acquired by Shenzhou Baekje."

"The price of 40 yuan a share is also very good, and the founder team has made a lot of money."

"This Shenzhou Baekje is really generous."

"Shenzhou Baekje is definitely behind Tianhai Group, Nuoan Group, and Jardine Group. These are large groups spanning multiple industries and have extremely strong financial resources."

·
As a result, the general meeting of shareholders shocked everyone.

Luo Cheng and others voted against more than 34%, vetoing Shenzhou Baekje Biologics' acquisition of Ogilvy Medical, thanks to Wan Lingxiang's 9% voting rights.

Chairman Chen Haohua: "Thank you, Mr. Luo. Although the price is high, I really don't want to be acquired by Shenzhou Baekje. Now I have turned against Wu Tianhai, and I will rely on you Chengtian Holdings and Fuxing Medicine in the future."

The Chengtian public offering fund under Chengtian Holdings has a heavy warehouse in the medical sector. It is a shareholder of major medical giants and has a certain influence. This time he turned against Shenzhou Baekje, and he also offended the Jardine Group behind Shenzhou Baekje. Nuoan Group, Tianhai Group, I am afraid that there will not be many good fruits in the future.

Luo Cheng comforted: "Mr. Chen, it's all about making money. Let's cooperate more in the future. In the future, Ogilvy Medical needs financing and debt issuance. You can come to me."

Chengtian Private Equity Fund and Chengtian Public Fund have a large scale, and they can fully support Ogilvy Medical when it needs to issue new shares for financing.

In the future, the Chengtian Public Fund Management Department will also set up a bond fund, which will be used to purchase corporate debt in the future. If you have a good relationship with that listed company, you can use it to purchase its corporate bonds and support it. This is Luo Cheng's support and support for others. If he can't do the enemy's job in various industries, he will support the enemy's opponent to do it.

For example, Chengtian Hotel Group has been engaged by Kaiyuan Hotel Group in various ways. It cannot compete with its opponents, but it can support New Century Hotel Group's competitor, Huatian Hotel Group.

Luo Cheng is even more inferior to Tianhai Group, Nuoan Group, and Jardine Group in the real industry, but he can also support and support their enemies.

This time, Shenzhou Baekje's plan to acquire Ogilvy Medical was shattered, which affected the strategic layout of Shenzhou Baekje, and must have caused a lot of losses. Wu Tianhai must be unhappy, and Luo Cheng is happy to do such a thing.

Chen Haohua smiled and said, "Mr. Luo, I plan to let Ogilvy Medical's spare funds subscribe to your Chengtian Public Fund. After all, I like stable income. Haha, everyone will cooperate more in the future."

Chen Haohua doesn't like high-risk investments, so instead of investing in Chengtian Private Equity Fund, he chose Chengtian Public Fund.

"Good!" Luo Cheng was very happy.

On the spot, Chen Haohua used part of Ogilvy Medical's spare funds, totaling 2 million yuan, to subscribe for the Chengtian public offering fund and collected 500 million yuan in management fees.

Not bad.

Chen Haohua said again: "Mr. Luo, you have to be careful of Wu Tianhai in the future. He is very insidious and has a lot of tricks. This time he spent a long time planning to acquire Ogilvy Medical and bought many shareholders. He almost succeeded, but If you spoil his good deed, he will definitely mess with your Chengtian Holdings again."

Before Chengtian Holdings was raped by Wu Tianhai, the stock price plummeted, and Chengtian Public Fund was redeemed in large quantities.

Luo Cheng said nonchalantly: "Just come anyway."

But when he learned that Luo Cheng was doing bad things secretly, Wu Tianhai was so angry that he became angry from embarrassment.

"This kid is ruining my good deeds again!"

Wu Tianhai clenched his teacup tightly and slammed it on the table!

boom!
The water splashed on his face, and his face was terribly gloomy.

Before that, he carefully planned for a long time, asking Bai Qing to be his lover, and seeing success, Luo Cheng stepped in and forced Bai Qing to death, and then robbed Bai's West Lake villa, which made him very embarrassing.

Now he is ruining his good deeds again. Ogilvy Medical has been planning for him for a long time. If Ogilvy Medical is acquired this time, it can attack Fuxing Medicine, and it will also allow Shenzhou Baekje Biologics to obtain key patented technologies, which will enable Shenzhou Baekje Biological Company is more competitive.

But this Luo Cheng came out and destroyed his layout.

This definitely can't be forgotten like this, and they have to retaliate severely in business.

Not only Wu Tianhai of Tianhai Group was furious, but Jardine Group and Nuoan Group were also furious!
"This Chengtian Holdings dares to meddle in our affairs with Fuxing Medicine."

"Cao, a small company with a market value of over [-] billion yuan really takes itself seriously!"

····
Shenzhou Baekje Biological Company's acquisition of Ogilvy Medical failed because of Chengtian Holdings, which caused quite a stir in the industry.

"I didn't expect the acquisition of Shenzhou Baekje Biological Company to fail. I thought it would be a sure win."

"The power of Chengtian Holdings is quite strong, and it actually changed the situation."

"Now Chengtian Holdings has formed a bigger relationship with Tianhai Group, Nuoan Group, and Jardine Group."

"Tianhai Securities, Lion Securities, and Jardine Securities have engaged in Chengtian Holdings before, and this is just a reciprocity."

"Let me go, Tianhai Group, Nuoan Group, and Jardine Group are all very large groups. Can Chengtian Holdings compare?"

"It will be even more difficult for the subsidiaries of Chengtian Holdings in the future. If I am the financial god of Shanghai, I will definitely not dare to offend these three big groups."

"You must know that the market value of Shenzhou Baekje under the three major groups exceeds 3000 billion Hong Kong dollars, and Chengtian Holdings is far inferior to even a listed subsidiary group under them."

"Yes, the market value of Tianhai Securities is higher than that of Chengtian Holdings."

"Before, Tianhai Securities, Lion Securities, and Jardine Securities caused the stock price of Chengtian Holdings to plummet, and Chengtian's public offering funds were redeemed in large numbers. This time, the God of Finance in Shanghai is just fighting back."

"Hey, if I were the God of Finance in Shanghai, I would definitely endure it and not offend the three big groups!"

"Especially the Jardine Group, which is a big consortium in Xiangjiang. It will be difficult when Chengtian Holdings goes to Xiangjiang in the future."

At this time, someone said: "I'm going, the God of Finance in Shanghai is so annoying, what are you afraid of? Last time the three groups established Chengtian Holdings, and the God of Finance in Shanghai didn't fight back. Is he still the God of Finance in Shanghai?"

"Great job by the God of Finance in the capital city. I have long been displeased with the Tianhai Group and the Nuoan Group."

···
On the next day, March 3th, Tuesday, before the stock market opened, Fuxing Pharmaceutical announced that it would expand production, and it might give Ogilvy Medical a large order of 5 billion.

Ogilvy's share price soared that day.

41.56
42.78
43.79
···
50 yuan per share, a record high! ·

Zhou Yuanping, Zhang Hanlin, and Ling Guangchang also sold their holdings in Ogilvy Medical and invested 2000 million each. This time they made a lot of profit and made some small money.

The Roche Family Fund holds 1200 million shares of Ogilvy Medical, already worth 6 million.

The president of Fuxing Medicine approached Luo Cheng and wanted to buy the shares of Ogilvy Medical held by the Luo Family Foundation.

At the market price, 50 yuan per share, purchase.

"Mr. Luo, we plan to buy the equity of Ogilvy Medical in your hand. What's the market price?"

Luo Cheng agreed immediately, sold the 1200 million shares, and got 6 million. This time, he took a heavy position in Ogilvy Medical, and the 3 million became 6 million, and the profit was 100%, which is very good.

(End of this chapter)